BioMarin Pharmaceutical Inc.

05/05/2022 | Press release | Distributed by Public on 05/05/2022 06:33

BioMarin to Present Findings from Ongoing Studies of Valoctocogene Roxaparvovec, Investigational Gene Therapy, at the World Federation of Hemophilia 2022 World Congress, May[...]